NASDAQ:NVCR

Novocure Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy NVCR

*Your capital is at risk

$16.15

+0.330 (+2.09%)

At Close: Jun 03, 2026

NovoCure Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 34.29. In total, the insiders bought 2.79M and sold 223.1K NVCR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	34.29
● Buy	2.79M shares
● Sell	223.1K shares
76% Buy Activity Moderate Positive Correlation
Sell Signal Low Confidence Mar 05, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 34.29. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 28, 2026 Buy	Ordinary Shares M-Exempt	Vernon W Anthony Director	Director	21 500 Value: $244.9K
Apr 28, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Vernon W Anthony Director	Director	21 500 Value: $244.9K
Mar 05, 2026 Sell	Ordinary Shares S-Sale	Paravasthu Mukund Chief Operating Officer	C-Suite Officer	43 246 Value: $595.7K
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Paravasthu Mukund Chief Operating Officer	C-Suite Officer	5 377 Value: $71.5K
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Leonard Frank X Chief Executive Officer	CEO / President	5 607 Value: $74.6K
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Brackmann Christoph Chief Financial Officer	C-Suite Officer	6 412 Value: $85.3K
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Weinberg Uri Chf Medical And Innovation Ofr	Officer	6 412 Value: $85.3K
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Leupin Nicolas Former Chief Medical Officer	Officer	1 100 Value: $14.6K
Mar 04, 2026 Sell	Ordinary Shares F-InKind	Cordova Ashley Former Chief Executive Officer	CEO / President	17 638 Value: $234.6K
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Puri Michal Nath Chief Human Resources Officer	Officer	1 100 Value: $14.6K
Mar 03, 2026 Buy	Ordinary Shares A-Award	Puri Michal Nath Chief Human Resources Officer	Officer	40 100 Value: $533.3K
Mar 03, 2026 Buy	Stock Option (Right to Buy) A-Award	Paravasthu Mukund Chief Operating Officer	C-Suite Officer	7 518 Value: $100.0K
Mar 03, 2026 Buy	Stock Option (Right to Buy) A-Award	Paravasthu Mukund Chief Operating Officer	C-Suite Officer	58 488 Value: $777.9K
Mar 03, 2026 Buy	Ordinary Shares A-Award	Paravasthu Mukund Chief Operating Officer	C-Suite Officer	45 112 Value: $600.0K
Mar 03, 2026 Buy	Stock Option (Right to Buy) A-Award	Leonard Frank X Chief Executive Officer	CEO / President	216 388 Value: $2.88M
Mar 03, 2026 Buy	Ordinary Shares A-Award	Leonard Frank X Chief Executive Officer	CEO / President	150 000 Value: $2.00M
Mar 03, 2026 Buy	Stock Option (Right to Buy) A-Award	Brackmann Christoph Chief Financial Officer	C-Suite Officer	80 674 Value: $1.07M
Mar 03, 2026 Buy	Stock Option (Right to Buy) A-Award	Weinberg Uri Chf Medical And Innovation Ofr	Officer	73 340 Value: $975.4K
Mar 03, 2026 Buy	Ordinary Shares A-Award	Ben Arye Barak General Counsel	Officer	50 125 Value: $666.7K
Mar 03, 2026 Buy	Stock Option (Right to Buy) A-Award	Ben Arye Barak General Counsel	Officer	73 340 Value: $975.4K
Mar 03, 2026 Buy	Ordinary Shares A-Award	Weinberg Uri Chf Medical And Innovation Ofr	Officer	50 125 Value: $666.7K
Mar 03, 2026 Buy	Ordinary Shares A-Award	Brackmann Christoph Chief Financial Officer	C-Suite Officer	55 137 Value: $733.3K
Mar 03, 2026 Buy	Stock Option (Right to Buy) A-Award	Puri Michal Nath Chief Human Resources Officer	Officer	58 672 Value: $780.3K
Mar 03, 2026 Buy	Ordinary Shares A-Award	Doyle William F Executive Chairman	CEO / President	200 284 Value: $2.66M
Mar 03, 2026 Sell	Ordinary Shares S-Sale	Doyle William F Executive Chairman	CEO / President	50 557 Value: $646.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NOVOCURE LIMITED

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c...

Read Full Profile Here